Angel City Research | Los Angeles, CA

Research site

(Unclaimed)

Location

3333 Wilshire Blvd Suite500, Los Angeles, California, United States of America

Site insights

Top conditions

Top treatments

Relamorelin

Semaglutide

Suzetrigine

TQJ230

SUZ

Pelacarsen

CIN-102

MHS-1031

Deudomperidone

NG101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 23 total trials

A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

The main objective of this study is:To assess the efficacy and safety of EscharEx (EX-03 5% formulation) compared to placebo control,in debridement a...

Enrolling

Venous Leg Ulcer (VLU)

Drug: Placebo (Gel vehicle)

Drug: EscharEx (EX-03)

Locations recently updated

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compa...

Invitation-only

Venous Leg Ulcer

Diabetic Foot Ulcer

Device: AmnioExcel Plus for Venous Leg Ulcers

Device: Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: Semaglutide

Drug: Placebo (semaglutide)

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabet...

Enrolling

Diabetic Peripheral Neuropathic Pain

Drug: Suzetrigine

Drug: Placebo (matched to Pregabalin)

Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated...

Active, not recruiting

Diabetic Peripheral Neuropathic Pain

Drug: Suzetrigine

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

A multi-center, prospective, observer-blinded, randomized controlled clinical trial to evaluate the efficacy of PPECM augmented standard of care vers...

Enrolling

Ulcer

Wound Heal

Device: InnovaMatrix® AC

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled trial to evaluate the effect of MHS-1031 on heartburn-fr...

Active, not recruiting

Gastroesophageal Reflux

Drug: MHS-1031

Other: Placebo

Pelacarsen Roll-over Extension Program

This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed e...

Enrolling

Atherosclerotic Cardiovascular Disease

Drug: Pelacarsen (TQJ230)

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/...

Enrolling

Chronic Foot Ulcers

Diabetic Foot Ulcer (DFU)

Other: Allograft

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 1 diabetic foot ulcers.

Active, not recruiting

Diabetic Foot

Biological: SkinTE

Other: Control

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers (Mavericks)

The purpose of this clinical trial is to evaluate the safety and effectiveness of the treatment with the COMS One device in subjects with refractory...

Enrolling

Diabetic Foot Ulcer

Device: COMS One device

Device: Sham device

Locations recently updated

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Active, not recruiting

Chronic Kidney Disease

Inflammation

Drug: Placebo (Ziltivekimab B)

Drug: Placebo (Ziltivekimab C)